Alpheus Medical Closes $16M In Series A Financing For Novel Glioma Brain Cancer Treatment
Funds to support first-in-human (FIH) clinical trial of the company's proprietary, non-invasive sonodynamic drug-device therapy system for recurrent high-grade gliomas
OAKDALE, Minn., Nov. 17, 2021 -- (Healthcare Sales & Marketing Network) -- Alpheus ... Devices, Oncology, Venture Capital Alpheus Medical, sonodynamic therapy, glioblastoma multiforme
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news
More News: Brain | Brain Cancers | Brain Tumor | Cancer | Cancer & Oncology | Clinical Trials | Glioma | Marketing | Neurology | Pharmaceuticals | Venture Capital